The 20 Best Sjogren Syndrome Doctors Near Me in Baltimore, MD

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as an Elite provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis. Dr. Baer is board certified in American Board Of Internal Medicine.

Dr. Grader-Beck is an Associate Professor of Clinical Medicine in the Rheumatology Division. Dr. Grader-Beck’s clinical expertise includes the diagnosis and treatment of Sjogren's syndrome as well as inflammatory arthritis. He has a specific interest in improving quality of patient care and clinical research using state of the art information technology. He is developing innovative ways in how clinicians and researchers can leverage electronic health record systems to deliver individualized patient care and precision medicine. Dr. Grader is rated as an Elite provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Interstitial Keratitis, and Dermatomyositis. Dr. Grader is board certified in American Board Of Preventive Medicine and American Board Of Internal Medicine.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as an Advanced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Cataract, Optic Atrophy Type 1, Vitrectomy, and Cataract Removal.

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as an Advanced provider by MediFind in the treatment of Sjogren Syndrome. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy. Dr. Petri is board certified in American Board Of Internal Medicine and American Board Of Allergy And Immunology.

Dr. Antiochos sees patients in the Division of Rheumatology on the Bayview campus and conducts basic science research into the pathogenesis of rheumatic diseases in the Division's laboratory. Lab website: Brendan Antiochos MD. Dr. Antiochos is rated as an Advanced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Necrotizing Vasculitis, Sjogren Syndrome, and Vasculitis.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is rated as an Advanced provider by MediFind in the treatment of Sjogren Syndrome. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis. Dr. Cappelli is board certified in American Board Of Internal Medicine.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal. Dr. Berkenstock is board certified in American Board Of Ophthalmology.

Dr. Antony Rosen was an Osler resident and rheumatology fellow at Johns Hopkins Hospital before joining the faculty at Johns Hopkins, where he was appointed a professor in 2002. He served as director of the Division of Rheumatology between 2002 and 2022, overseeing a substantial expansion in the fellowship program and building the faculty from 14 to 26, and has been the Vice Dean for Research since 2013. Dr. Rosen received his medical degree from the University of Cape Town in South Africa in 1984 with first-class honors. After completing his internship in medicine & surgery and a year of postdoctoral study in medical biochemistry, he joined Dr. Alan Aderem at the Rockefeller University to pursue postdoctoral studies in immunology and cellular biology. Dr. Rosen is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Polymyositis, Scleroderma, and Systemic Sclerosis (SSc). Dr. Rosen is board certified in American Board Of Internal Medicine.

Michael Sulewski, M.D., is the James and Heather Gills Rising Professor of Ophthalmology and a cornea and cataract specialist at the Wilmer Eye Institute’s Baltimore locations at Bayview Medical Center and the Patient Access Center for the Eye at The Johns Hopkins Hospital, as well as in White Marsh, Maryland. Dr. Sulewski is also the ophthalmology residency program director. Dr. Sulewski specializes in cataract surgery, intraocular lens complications, corneal transplantation, keratoprosthesis, refractive surgery and other medical and surgical diseases of the cornea and anterior segment of the eye. Dr. Sulewski is also a resident supervisor at the Wilmer Eye Institute Patient Center for the Eye at The Johns Hopkins Hospital. Recent News Articles and Media Coverage Five Questions for Michael Sulewski, Johns Hopkins Medicine (Dec. 2020). Dr. Sulewski is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cataract, Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE), Cogan's Syndrome, Interstitial Keratitis, and Cataract Removal. Dr. Sulewski is board certified in American Board Of Ophthalmology.

Samuel C. Yiu, M.D., Ph.D., is an associate professor of ophthalmology at the Wilmer Eye Institute, specializing in cornea and external eye diseases, cataracts and refractive surgery (LASIK). In addition, he is a nationally and internationally recognized specialist in ocular surface diseases and ocular surface reconstruction surgery. Dr. Yiu received his M.Sc. (applied biometry) and Ph.D. (physiology and biophysics) from the University of Southern California. He then completed a post-doctoral fellowship in lacrimal physiology at the Schepens Eye Institute at Harvard Medical School and went on to earn his M.D. from the University of Alberta in Canada. Dr. Yiu completed an internship and his ophthalmology residency at Dalhousie University in Halifax, Nova Scotia and a fellowship in cornea, external disease and refractive surgery at the University of Southern California’s Doheny Eye Institute. After serving as the director of Doheny’s Ocular Surface Center and co-director of Doheny’s cornea division, Dr. Yiu joined the Wilmer faculty in 2011 and spent two years as the chief of the cornea division at King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Riyadh, Saudi Arabia, before returning to Baltimore in 2013. Dr. Yiu is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Cataract, Interstitial Keratitis, Dry Eye Syndrome, and Cloudy Cornea. Dr. Yiu is board certified in American Board Of Ophthalmology.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma. Dr. Wigley is board certified in American Board Of Internal Medicine.

Dr. Clifton Bingham is a Professor of Medicine, Director of the Johns Hopkins Arthritis Center, Director of the Center for Patient-Centered Outcomes Research in Rheumatology, Deputy Director for Research in the Division of Rheumatology, and Co-Director of the Rheumatic Diseases Research Core Center. He received his M.D. from Columbia University, where he also completed his Internal Medicine residency. He trained as a Fellow in both Rheumatology and in Allergy and Clinical Immunology at the Brigham and Women’s Hospital. Before coming to Hopkins in 2005, he was on faculty at NYU Hospital for Joint Diseases, where he founded a pioneering clinical and translational research center in rheumatology. He now directs the Johns Hopkins Arthritis Center, a group of 8 rheumatologists, 2 nurses, and a large clinical and research staff that sees more than 4500 patient visits each year, an integrates research with clinical care. His clinical interests are in the care of people living with Rheumatoid Arthritis (RA) and other forms of inflammatory arthritis. Dr. Bingham’s research experience has been diverse, and across the research continuum from bench to bedside. His early work focused on understanding the cytokine regulation of inflammatory mediator generation operative in rheumatologic and allergic diseases. He conducted prior translational research to better understand the role of initiating and amplifying pathways in RA, and has ongoing collaborations with several basic researchers to identify biomarkers for improved patient phenotyping and outcome prediction. Additional multidisciplinary clinical and translational work has focused on the role of periodontal disease and oral bacteria as triggers of RA. In the realm of clinical research, he has served as principal investigator and helped to design and analyze a number of NIH and industry-sponsored clinical trials of multiple agents in early to late phases of development for RA, psoriatic arthritis, and osteoarthritis. He has led several studies of the effects of biological and immunomodulatory therapies on responses to immunizations. A large amount of his current research is focused in the area of patient centered outcomes research, including patient reported outcome development, validation, and integration in clinical care. He serves as a member of the Executive Leadership Committee for the international Outcome Measures in Rheumatology (OMERACT) methodology group. He has authored more than 170 original research articles, reviews, and editorials, and 12 book chapters. He served as a Co-Editor for the journal of the American College of Rheumatology, Arthritis and Rheumatology, and as a reviewer for a number of rheumatology journals and national and international grant reviews. Dr. Bingham is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Myositis, and Psoriatic Arthritis. Dr. Bingham is board certified in American Board Of Internal Medicine.

Dr. Uzma Haque is an Assistant Professor of Medicine at the Arthritis Center at The Hopkins Bayview Medical Center, and is actively engaged in clinical care to patients with general rheumatic and musculoskeletal disorders. Dr. Haque is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, and Psoriasis. Dr. Haque is board certified in American Board Of Internal Medicine.

Dr. Hellmann is one of Johns Hopkins best physicians, teachers, and program builders. He holds the Aliki Perroti endowed Chair, recognizing his leadership in education. Dr. Hellmann’s clinical care and research focus is on vasculitis. Over the last four years, Dr. Hellmann has evaluated over 200 patients with systemic vasculitis. Areas of interest have included granulomatosis with polyangiitis, temporal arteritis, Takayasu’s arteritis, and polyarteritis nodosa. Dr. Hellmann is director of the Johns Hopkins Center for Innovative Medicine which promotes patient-centered care through the creative collaboration of research, teaching, and patient care programs. Dr. Hellmann is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Behcet Disease, Necrotizing Vasculitis, Takayasu Arteritis, and Juvenile Temporal Arteritis. Dr. Hellmann is board certified in American Board Of Internal Medicine.

Howard Hauptman is a Rheumatologist practicing medicine in Baltimore, Maryland. He has been practicing medicine for over 44 years. Dr. Hauptman is rated as a Distinguished provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica.

Melody Chung is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Chung is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Myositis, and Dermatomyositis. Dr. Chung is board certified in American Board Of Internal Medicine.

John Miller is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Microscopic Polyangiitis, Scleroderma, Rheumatoid Arthritis (RA), and Erythromelalgia. Dr. Miller is board certified in American Board Of Internal Medicine.

David Eisenberg, M.D., practices internal medicine at Johns Hopkins Community Physicians Remington. He received his medical degree from Chicago Medical School, and also completed his residency in internal medicine at Hahneman University Hospital. Dr. Eisenberg is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Maturity Onset Diabetes of the Young. Dr. Eisenberg is board certified in American Board Of Internal Medicine.

Jonathan Etter is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Etter is rated as an Advanced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Cataract, Blepharitis, and Sjogren Syndrome.

Jeffrey Wexler is an Ophthalmologist practicing medicine in Baltimore, Maryland. Dr. Wexler is rated as an Advanced provider by MediFind in the treatment of Sjogren Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Cataract, Glaucoma, Interstitial Keratitis, and Age-Related Macular Degeneration (ARMD).